BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15750617)

  • 21. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients.
    Charrier S; Dupré L; Scaramuzza S; Jeanson-Leh L; Blundell MP; Danos O; Cattaneo F; Aiuti A; Eckenberg R; Thrasher AJ; Roncarolo MG; Galy A
    Gene Ther; 2007 Mar; 14(5):415-28. PubMed ID: 17051251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.
    Candotti F; Facchetti F; Blanzuoli L; Stewart DM; Nelson DL; Blaese RM
    Gene Ther; 1999 Jun; 6(6):1170-4. PubMed ID: 10455421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
    Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
    Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction.
    Dupré L; Trifari S; Follenzi A; Marangoni F; Lain de Lera T; Bernad A; Martino S; Tsuchiya S; Bordignon C; Naldini L; Aiuti A; Roncarolo MG
    Mol Ther; 2004 Nov; 10(5):903-15. PubMed ID: 15509508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Boztug K; Dewey RA; Klein C
    Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.
    Dupré L; Marangoni F; Scaramuzza S; Trifari S; Hernández RJ; Aiuti A; Naldini L; Roncarolo MG
    Hum Gene Ther; 2006 Mar; 17(3):303-13. PubMed ID: 16544979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Was cDNA sequences modulate transgene expression of was promoter-driven lentiviral vectors.
    Toscano MG; Benabdellah K; Muñoz P; Frecha C; Cobo M; Martín F
    Hum Gene Ther; 2009 Nov; 20(11):1279-90. PubMed ID: 19630517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis.
    Serafini M; Bonamino M; Golay J; Introna M
    Haematologica; 2004 Jan; 89(1):86-95. PubMed ID: 14754610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
    Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
    Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
    Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
    Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector.
    Hiller C; Wittmann S; Slavin S; Fickenscher H
    Gene Ther; 2000 Apr; 7(8):664-74. PubMed ID: 10800089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells.
    Zhang J; Attar E; Cohen K; Crumpacker C; Scadden D
    Gene Ther; 2005 Oct; 12(19):1444-52. PubMed ID: 15877047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection.
    Richard E; Mendez M; Mazurier F; Morel C; Costet P; Xia P; Fontanellas A; Geronimi F; Cario-André M; Taine L; Ged C; Malik P; de Verneuil H; Moreau-Gaudry F
    Mol Ther; 2001 Oct; 4(4):331-8. PubMed ID: 11592836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS.
    Zanta-Boussif MA; Charrier S; Brice-Ouzet A; Martin S; Opolon P; Thrasher AJ; Hope TJ; Galy A
    Gene Ther; 2009 May; 16(5):605-19. PubMed ID: 19262615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpesvirus saimiri-based vector biodistribution using noninvasive optical imaging.
    Smith PG; Oakley F; Fernandez M; Mann DA; Lemoine NR; Whitehouse A
    Gene Ther; 2005 Oct; 12(19):1465-76. PubMed ID: 15889136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
    Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
    J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
    Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
    Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.
    Beutelspacher SC; Ardjomand N; Tan PH; Patton GS; Larkin DF; George AJ; McClure MO
    Exp Eye Res; 2005 Jun; 80(6):787-94. PubMed ID: 15939034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.